|
||
|
Adenosine Therapeutics,LLC
Download PDF Members: Adenosine Therapeutics (AT), located in Charlottesville, VA, is a drug discovery and development company that was co-founded in 1999 by University of Virginia (UVa) Professor, Joel Linden and entrepreneur, Robert Capon (one of three cofounders of Virologic, NASDAQ: VLGC.) Although relatively young as a company, AT represents the fruition of over 40 years of academic research at UVa on the pharmacology and physiology of the endogenous neucleoside, adenosine. UVa's establishment as the academic leader in adenosine research began with the work of Dr. Robert Berne in the 1960s. This led to the patent, clinical development, and successful marketing of the anti-arrhythmic, Adenocard®, a staple in ambulances and paramedic kits.
This page has been viewed 236 times since April 2007, the link to the organisation's website has been followed 45 times Recent Search Terms used to find this page: Adenocard | adenosine therapeutics | Joel Linden CV Therapeutics | adenosine | @adenrx.com | Director adenrx.com | adenosine therapeutics | . Search for more companies in Charlottesville Search for more companies in Virginia This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Adenosine Therapeutics,LLC | |||||||||||||||||||||||||||||||||||||||||
Nothing in this website should be used in place of personal medical
advice from your own qualified medical practitioner. See
User
Agreement |
All rights reserved. All other trademarks recognized. |
|
|